the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy

NCT ID: NCT00497588

Last Updated: 2013-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-03-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

early laryngeal cancer is a well known field with great controversy in treatment. two options are available in treatment of patients the first one is partial laryngectomy and the second one is radiotherapy.one of major concern of patients have been the quality of voice ,so we design this trial to answer the priority of each options.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

early laryngeal cancer is a well known field with great controversy in treatment. two options are available in treatment of patients the first one is partial laryngectomy and the second one is radiotherapy.one of major concern of patients have been the quality of voice as part of quality of life ,so we design this clinical randomised trial to answer the priority of each options.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Voice Quality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

radiotherapy

patients receive radiotherapy

Group Type ACTIVE_COMPARATOR

radiotherapy

Intervention Type RADIATION

surgery

Patients undergo surgery

Group Type EXPERIMENTAL

surgery

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgery

Intervention Type PROCEDURE

radiotherapy

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Early laryngeal cancer

Exclusion Criteria

* No history of radiotherapy and collagen vascular disease
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tehran University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Babak Saedi

associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

babak saedi, professor

Role: PRINCIPAL_INVESTIGATOR

tehran university of medical science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Imam Khomainee hospital

Tehran, Tehran Province, Iran

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Iran

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

babak saedi, professor

Role: CONTACT

98219123872469

mohamad sadeghi, professor

Role: CONTACT

98219121153594

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

babak saedi, professor

Role: primary

98219123872469

Mohamad sadeghi, professor

Role: backup

98219121153594

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

bs-86-01-48-5497

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.